, gastroenterology-oncology, and thoracic therapeutic areas. Sigvotatug Vedotin (SV) is a pre-launch medicine currently being studied... and Thoracic US franchise. This role will lead the US launch efforts for SV in 2L NSCLC (launch readiness lead...